Evaluation of Physical and Functional Status in Patients With COVID-19 in Long Term
Evaluation of Exercise Capacity, Peripheral Muscle Strength, Balance, Cognitive Status and Quality of Life in Patients With COVID-19 in Long Term
1 other identifier
observational
40
1 country
1
Brief Summary
The reason the investigators want to do this research; Especially after Covid-19 infection, no research has been found on functional status in the long term. Therefore, in our study, the investigators aimed to evaluate exercise capacity, functional status, peripheral muscle strength, balance, anxiety and depression level, consciousness, work productivity, pain, fear of movement, and quality of life in patients with Covid-19 and to compare them with healthy individuals who have not had COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 16, 2021
CompletedFirst Submitted
Initial submission to the registry
April 7, 2021
CompletedFirst Posted
Study publicly available on registry
April 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2022
CompletedAugust 9, 2022
August 1, 2022
12 months
April 7, 2021
August 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incremental shuttle walking test
It assesses maximal exercise capacity.
January,2021 - December,2021
Secondary Outcomes (9)
Time up and Go Test
January,2021 - December,2021
Short form McGill-Melzack Pain Questionnaire
January,2021 - December,2021
Tampa Kinesophobia Questionnaire
January,2021 - December,2021
Hospital Anxiety and Depression Scale
January,2021 - December,2021
SF-36 Quality of Life Scale
January,2021 - December,2021
- +4 more secondary outcomes
Study Arms (2)
people with a history of COVID-19
COVID-19 Group Inclusion Criteria * Having been diagnosed with COVID-19 at least 12 weeks ago, * Being literate, * Being in the age range of 18-65, * Volunteering to participate in research, * To be clinically stable, to be under control if any accompanying comorbid conditions (such as hypertension, diabetes), * Not having any orthopedic and neurological problems that might interfere with evaluating peripheral muscle strength, balance and exercise capacity. COVID-19 Group Exclusion Criteria * Those with an ICU hospitalization history due to the diagnosis of COVID-19, * Recent myocardial infarction and pulmonary embolism. * Having accompanying chronic diseases, * Those who have any orthopedic or neurological disorders that will prevent walking, * Another COVID-19 PCR Test positivity in the last 12 weeks, * Not being able to cooperate and adapt to exercise test due to neurological influences such as cerebrovascular disease or psychiatric disorders,
healthy people
Healthy Group Inclusion Criteria * Not having COVID-19, * Being literate, * Being in the age range of 18-65, * Volunteering to participate in research. The Criteria for Not Including the Healthy Group in the Study * Those who have any orthopedic or neuromuscular disorders that will prevent walking, * Having any chronic illness or psychiatric conditions or mental afflictions that may interfere with cooperation or compliance with exercise tests.
Eligibility Criteria
The population of the study is individuals who live in Ankara and have passed the diagnosis of COVID-19 for at least 12 weeks and healthy individuals who have not had COVID-19. The sample of the study is healthy individuals in the long term after the diagnosis of COVID-19 at least 12 weeks after the diagnosis of COVID-19 and healthy individuals who have not had COVID-19 in Hacettepe University Adult Hospital who meet the inclusion criteria and volunteer to participate in the study.
You may qualify if:
- Having been diagnosed with COVID-19 at least 12 weeks ago,
- Being literate,
- Being in the age range of 18-65,
- Volunteering to participate in research,
- To be clinically stable, to be under control if any accompanying comorbid conditions (such as hypertension, diabetes),
- Not having any orthopedic and neurological problems that might interfere with evaluating peripheral muscle strength, balance and exercise capacity.
You may not qualify if:
- Recent myocardial infarction and pulmonary embolism.
- Having accompanying chronic diseases,
- Those who have any orthopedic or neurological disorders that will prevent walking,
- Another COVID-19 PCR Test positivity in the last 12 weeks,
- Not having COVID-19,
- Being literate,
- Being in the age range of 18-65,
- Volunteering to participate in research. The Criteria for Not Including the Healthy Group in the Study
- Those who have any orthopedic or neuromuscular disorders that will prevent walking,
- Having any chronic illness or psychiatric conditions or mental afflictions that may interfere with cooperation or compliance with exercise tests.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Turkey (Türkiye)
Related Publications (5)
Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020 Aug;54(16):949-959. doi: 10.1136/bjsports-2020-102596. Epub 2020 May 31.
PMID: 32475821RESULTXu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18. No abstract available.
PMID: 32085846RESULTZhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020 May;19(5):383-384. doi: 10.1016/S1474-4422(20)30109-5. Epub 2020 Apr 1. No abstract available.
PMID: 32246917RESULTEpidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. Chinese.
PMID: 32064853RESULTBelli S, Balbi B, Prince I, Cattaneo D, Masocco F, Zaccaria S, Bertalli L, Cattini F, Lomazzo A, Dal Negro F, Giardini M, Franssen FME, Janssen DJA, Spruit MA. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur Respir J. 2020 Oct 15;56(4):2002096. doi: 10.1183/13993003.02096-2020. Print 2020 Oct.
PMID: 32764112RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Gülay Sain-Guven, Professor
Hacettepe University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 7, 2021
First Posted
April 8, 2021
Study Start
February 16, 2021
Primary Completion
February 3, 2022
Study Completion
February 3, 2022
Last Updated
August 9, 2022
Record last verified: 2022-08